The first case of congenital Chagas’ disease analyzed by AP-PCR in Colombia
Keywords:
Chagas disease, Trypanosoma cruzi, maternal-fetal exchange, polymerase chain reaction, Colombia, AP-PCR.
Abstract
Introduction. The main route of Chagas disease transmission is through vectors of the insect family Reduviidae. However, the parasite can also be transmitted from infected mothers to their fetus in utero. Until now, no cases of congenital Chagas disease have been reported in Colombia.Objective. A congenital Chagas disease case occurred in Moniquirá County, Boyacá, Colombia. It was confirmed by comparing strains isolated from the mother and her baby using polymerase chain reaction (PCR) with arbitrary primers.
Materials and methods. The parasite DNA was extracted from positive blood cultures of the aflicted mother and her son. The species confirmation and group detection were performed by PCR. The strain genotypes were determined by AP-PCR with two oligonucleotides based on the genes for the b-globin (5’-CCTCACCTTCTTTCATGGAG-3’) and 16S RrNA (5’-ACGGGCAGTGTGTACAAGACC-3’), in differente reactions.
Results. The T. cruzi strains isolated from the blood cultures of the mother and her son showed the same amplification profile by the two AP-PCR tests; this corresponded with profiles of the T.cruzi I strains used as controls. However, T. cruzi II was also found in the blood culture from the newborn.
Conclusions. This is the first case of Chagas disease transmission reported in Moniquirá, demonstrating that this form of transmission occurs in Colombia. The presence of both groups of T. cruzi in the newborn sample suggests mixed infection in the mother as well, with a higher prevalence of T. cruzi I, at least in the mother’s blood culture.
Downloads
Download data is not yet available.
References
1. World Health Organization. Control of Chagas disease. Report of a WHO Expert Committee. Technical Report Series 905. Geneva: WHO; 2002. p. 82-3.
2. Schofield CJ, Jannin J, Salvatella R. The future of Chagas disease control. Trends Parasitol. 2006;22: 583-8.
3. World Health Organization. Control of Chagas disease. Report of a WHO Expert Committee. Technical Report Series 811. Geneva: WHO; 1991. p. 1-95.
4. Blanco SB, Segura EL, Cura EN, Chuit R, Tulián L, Flores I, et al. Congenital transmission of Trypanosoma cruzi: an operacional outline for detecting and treating infected infants in north-western Argentina. Trop Med Int Health. 2000;5:293-301.
5. Luquetti AO, Dias JC, Prata, A. Diagnosis and treatment of congenital infection caused by Trypanosoma cruzi in Brazil. Parasitol Res. 2006;99:379-83.
6. Rosa R, Basnadjian Y, González MM, González M, Salvatella R. Actualización clínico-epidemiológica y terapéutica de la enfermedad de Chagas en Uruguay. Rev Med Uruguay. 2001;17:125-32.
7. Moncayo A. Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries. Mem Inst Oswaldo Cruz. 2003;98:577-91.
8. Guhl F, Nicholls RS. Manual de procedimientos para el diagnóstico de la enfermedad de Chagas. Bogotá, D.C.: Quebecor Impresores; 2001.
9. Pavía P, Cuervo C, Montilla M, Nicholls S, Puerta C. Diseño y estandarización de una prueba de PCR para la detección específica de Trypanosoma cruzi. Infectio. 2003;7:129-36.
10. Pavia P, Vallejo GA, Montilla M, Nicholls RS, Puerta CJ. Detection of Trypanosoma cruzi and Trypanosma rangeli infection in triatomine vectors by amplification histone H2A and sno-RNA-CL1 genes. Rev Inst Med Trop Sao Paulo. 2007;49:23-30.
11. Duque S, Peláez D, Corredor A. Normas para cultivo in vitro de parásitos de la familia trypanosomatidae. Manual de procedimientos. Bogotá, D.C.: Instituto Nacional de Salud; 1993.
12. Sturm NR, Degrave W, Morel C, Simpson L. Sensitive detection and schizodeme classification of Trypanosoma cruzi cells by amplification of kinetoplast minicircle DNA sequences: use in diagnosis of Chagas disease. Mol Biochem Parasitol. 1989;33:205-14.
13. Yeo M, Acosta N, Llewellyn M, Sánchez H, Adamson S, Miles GA, et al. Origins of Chagas disease: Didelphis species are natural hosts of Trypanosoma cruzi I and armadillos hosts of Trypanosoma cruzi II, including hybrids. Int J Parasitol. 2005;35:225-33.
14. Saldaña CH, Cordova OP, Vargas FV. Utilización de Lepidium peruvianum (Maca), como medio de cultivo para el crecimiento de T. cruzi. Rev Peru Med Exp Salud Pública. 2006;23:137-40.
15. Virreira M, Torrico F, Truyens C, Alonso-Vega C, Solano M, Carlier Y, et al. Comparison of polymerase chain reaction methods for reliable and easy detection of congenital Trypanosoma cruzi infection. Am J Trop Med Hyg. 2003;68:574-82.
16. Hypsa V, Dale C. In vitro culture and phylogenetic analysis of “Candidatus Arsenophorus triatominarum,” an intracellular bacterium from the triatomine bug, Triatoma infestans. Int J Syst Bacteriol. 1997;47:1140-4.
17. Welsh J, McClelland M. Fingerpriting genomes using PCR with arbitrary primers. Nucleic Acids Res. 1990;18:7213-8.
18. Triquell MF, Díaz-Luján C, Freilij H, Paglini P, Fretes RE. Placental infection by two subpopulations of Trypanosoma cruzi is conditioned by differential survival of the parasite in a deleterious placental medium and not by tissue reproduction. Trans R Soc Trop Med Hyg. 2009 Mar 30. [Epub ahead of print]
19. Franco DJ, Vago AR, Chiari E, Meira FC, Galvao LM, Machado CR. Trypanosoma cruzi: mixture of two populations can modify virulence and tissue tropism in rat. Exp Parasitol. 2003;104:54-61.
20. Liarte DB, Murta SM, Steindel M, Romanha AJ. Trypanosoma cruzi: Multiplex PCR to detect and classify strains according to groups I and II. Exp Parasitol. 2008. doi 10.1016/j.exppara.2008.12.005. [Epub ahead of print].
21. Botero LA, Mejía AM, Triana O. Caracterización biológica y genética de dos clones pertenecientes a los grupos I y II de Trypanosoma cruzi de Colombia. Biomédica. 2007;27(Suppl.1)1:64-74.
22. Neto EC, Rubin R, Schulte J, Giugliani R. Newborn screening for congenital infectious disease. Emerg Infect Dis. 2004;10:1068-73.
23. Freilij H, Altcheh J. Congenital Chagas disease: diagnostic and clinical aspects. Clin Infect Dis. 1995;21;551-5.
24. Carlier Y, Torrico F. Congenital infection with Trypanosoma cruzi: from mechanisms of transmission to strategies for diagnosis and control. Rev Soc Brasil Med Trop. 2003;6:767-71.
2. Schofield CJ, Jannin J, Salvatella R. The future of Chagas disease control. Trends Parasitol. 2006;22: 583-8.
3. World Health Organization. Control of Chagas disease. Report of a WHO Expert Committee. Technical Report Series 811. Geneva: WHO; 1991. p. 1-95.
4. Blanco SB, Segura EL, Cura EN, Chuit R, Tulián L, Flores I, et al. Congenital transmission of Trypanosoma cruzi: an operacional outline for detecting and treating infected infants in north-western Argentina. Trop Med Int Health. 2000;5:293-301.
5. Luquetti AO, Dias JC, Prata, A. Diagnosis and treatment of congenital infection caused by Trypanosoma cruzi in Brazil. Parasitol Res. 2006;99:379-83.
6. Rosa R, Basnadjian Y, González MM, González M, Salvatella R. Actualización clínico-epidemiológica y terapéutica de la enfermedad de Chagas en Uruguay. Rev Med Uruguay. 2001;17:125-32.
7. Moncayo A. Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries. Mem Inst Oswaldo Cruz. 2003;98:577-91.
8. Guhl F, Nicholls RS. Manual de procedimientos para el diagnóstico de la enfermedad de Chagas. Bogotá, D.C.: Quebecor Impresores; 2001.
9. Pavía P, Cuervo C, Montilla M, Nicholls S, Puerta C. Diseño y estandarización de una prueba de PCR para la detección específica de Trypanosoma cruzi. Infectio. 2003;7:129-36.
10. Pavia P, Vallejo GA, Montilla M, Nicholls RS, Puerta CJ. Detection of Trypanosoma cruzi and Trypanosma rangeli infection in triatomine vectors by amplification histone H2A and sno-RNA-CL1 genes. Rev Inst Med Trop Sao Paulo. 2007;49:23-30.
11. Duque S, Peláez D, Corredor A. Normas para cultivo in vitro de parásitos de la familia trypanosomatidae. Manual de procedimientos. Bogotá, D.C.: Instituto Nacional de Salud; 1993.
12. Sturm NR, Degrave W, Morel C, Simpson L. Sensitive detection and schizodeme classification of Trypanosoma cruzi cells by amplification of kinetoplast minicircle DNA sequences: use in diagnosis of Chagas disease. Mol Biochem Parasitol. 1989;33:205-14.
13. Yeo M, Acosta N, Llewellyn M, Sánchez H, Adamson S, Miles GA, et al. Origins of Chagas disease: Didelphis species are natural hosts of Trypanosoma cruzi I and armadillos hosts of Trypanosoma cruzi II, including hybrids. Int J Parasitol. 2005;35:225-33.
14. Saldaña CH, Cordova OP, Vargas FV. Utilización de Lepidium peruvianum (Maca), como medio de cultivo para el crecimiento de T. cruzi. Rev Peru Med Exp Salud Pública. 2006;23:137-40.
15. Virreira M, Torrico F, Truyens C, Alonso-Vega C, Solano M, Carlier Y, et al. Comparison of polymerase chain reaction methods for reliable and easy detection of congenital Trypanosoma cruzi infection. Am J Trop Med Hyg. 2003;68:574-82.
16. Hypsa V, Dale C. In vitro culture and phylogenetic analysis of “Candidatus Arsenophorus triatominarum,” an intracellular bacterium from the triatomine bug, Triatoma infestans. Int J Syst Bacteriol. 1997;47:1140-4.
17. Welsh J, McClelland M. Fingerpriting genomes using PCR with arbitrary primers. Nucleic Acids Res. 1990;18:7213-8.
18. Triquell MF, Díaz-Luján C, Freilij H, Paglini P, Fretes RE. Placental infection by two subpopulations of Trypanosoma cruzi is conditioned by differential survival of the parasite in a deleterious placental medium and not by tissue reproduction. Trans R Soc Trop Med Hyg. 2009 Mar 30. [Epub ahead of print]
19. Franco DJ, Vago AR, Chiari E, Meira FC, Galvao LM, Machado CR. Trypanosoma cruzi: mixture of two populations can modify virulence and tissue tropism in rat. Exp Parasitol. 2003;104:54-61.
20. Liarte DB, Murta SM, Steindel M, Romanha AJ. Trypanosoma cruzi: Multiplex PCR to detect and classify strains according to groups I and II. Exp Parasitol. 2008. doi 10.1016/j.exppara.2008.12.005. [Epub ahead of print].
21. Botero LA, Mejía AM, Triana O. Caracterización biológica y genética de dos clones pertenecientes a los grupos I y II de Trypanosoma cruzi de Colombia. Biomédica. 2007;27(Suppl.1)1:64-74.
22. Neto EC, Rubin R, Schulte J, Giugliani R. Newborn screening for congenital infectious disease. Emerg Infect Dis. 2004;10:1068-73.
23. Freilij H, Altcheh J. Congenital Chagas disease: diagnostic and clinical aspects. Clin Infect Dis. 1995;21;551-5.
24. Carlier Y, Torrico F. Congenital infection with Trypanosoma cruzi: from mechanisms of transmission to strategies for diagnosis and control. Rev Soc Brasil Med Trop. 2003;6:767-71.
How to Cite
1.
Puerta CJ, Pavia PX, Montilla M, Flórez C, Herrera G, Ospina JM, et al. The first case of congenital Chagas’ disease analyzed by AP-PCR in Colombia. biomedica [Internet]. 2009 Dec. 1 [cited 2024 May 16];29(4):513-22. Available from: https://revistabiomedica.org/index.php/biomedica/article/view/125
Some similar items:
- Ernesto Pérez-Sánchez, Raúl Montiel-Cruz, Eréndira Romero-Domínguez, Griselda Pascacio-Bermúdez, Arturo Báez-Hernández, Guadalupe Díaz del Castillo-Flores, Fabián Correa-Morales, Gonzalo Vázquez-Prokopec, Pablo Manrique-Saide, Azael Che-Mendoza, Gabriela Meneses-Ruiz , Irma López-Martínez, María Jesús Sánchez, Seroprevalence of Trypanosoma cruzi among children from Veracruz, Mexico: Epidemiological baseline for a control model based on Chagas disease active transmission , Biomedica: Vol. 44 No. 1 (2024)
- Patricia Escobar, Katherine Paola Luna, Indira Paola Hernández, César Mauricio Rueda, María Magdalena Zorro, Simon L. Croft, In vitro susceptibility of Trypanosoma cruzi strains from Santander, Colombia, to hexadecylphosphocholine (miltefosine), nifurtimox and benznidazole , Biomedica: Vol. 29 No. 3 (2009)
- María Clara Echeverry, Nubia Catalina Tovar, Guillermo Mora, Presence of antibodies to cardiac neuroreceptors in patients with Chagas disease , Biomedica: Vol. 29 No. 3 (2009)
- Concepción Judith Puerta, Johana María Guevara, Paula Ximena Pavía, Marleny Montilla, Rubén Santiago Nicholls, Edgar Parra, Yuli Katherine Barrera, Evaluation of TcH2AF-R and S35-S36 primers in PCR tests for the detection of Trypanosoma cruzi in mouse cardiac tissue , Biomedica: Vol. 28 No. 4 (2008)
- Olga Serrano, Florencio Mendoza, Benny Suárez, Ana Soto, Seroepidemiology of Chagas disease in two rural populations in the municipality of Costa de Oro, at Aragua State, northern Venezuela , Biomedica: Vol. 28 No. 1 (2008)
- Guillermo Mora, María Clara Echeverry, Gustavo Enrique Rey, Myriam Consuelo López, Luisa Fernanda Posada, Fabio Aurelio Rivas, Frequency of Trypanosoma cruzi infection in patients with implanted pacemaker , Biomedica: Vol. 27 No. 4 (2007)
- Ana María Perilla, Camilo González, Sandra Liliana Valderrama, Natasha Vanegas, Bibiana Chavarro, Luis Carlos Triana, José Roberto Támara, Carlos Arturo Álvarez, Necrotizing pneumonia by community-acquired, methicillin-resistant Staphylococcus aureus in Colombia , Biomedica: Vol. 29 No. 4 (2009)
- Yolanda Lucía López, Claudia González, Berta Natalia Gallego, Ana Lida Moreno, Stewardship of public health surveillance in the health system in Colombia: a cases study , Biomedica: Vol. 29 No. 4 (2009)
- Oscar Fernando Herrán, María F. Ardila, Categories of alcohol consumers and the criteria for classification , Biomedica: Vol. 29 No. 4 (2009)
- Rubén Santiago Nicholls, Zulma Milena Cucunubá, Angélica Knudson, Astrid Carolina Flórez, Marleny Montilla, Concepción Judith Puerta, Paula Ximena Pavía, Acute Chagas disease in Colombia: a rarely suspected disease. Report of 10 cases presented during the 2002-2005 period , Biomedica: Vol. 27 No. 1esp (2007): Enfermedad de Chagas
Published
2009-12-01
Issue
Section
Case presentation
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
